Xiaojing Xing

1.2k total citations
37 papers, 477 citations indexed

About

Xiaojing Xing is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaojing Xing has authored 37 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xiaojing Xing's work include MicroRNA in disease regulation (4 papers), CAR-T cell therapy research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Xiaojing Xing is often cited by papers focused on MicroRNA in disease regulation (4 papers), CAR-T cell therapy research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Xiaojing Xing collaborates with scholars based in China, United States and Hong Kong. Xiaojing Xing's co-authors include Xiaohu Gu, Yegang Ma, Bin Liu, Lianqing Liu, Mi Li, Leaf Huang, Chun Song, Yuehua Gong, Mien‐Chie Hung and Ning Xi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Xiaojing Xing

33 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojing Xing China 14 267 124 117 110 60 37 477
Reeti Behera United States 7 227 0.9× 125 1.0× 175 1.5× 97 0.9× 61 1.0× 10 571
Aino Paasinen-Sohns Finland 10 323 1.2× 63 0.5× 153 1.3× 138 1.3× 42 0.7× 13 517
Charles Vincent Rajadurai Canada 9 251 0.9× 91 0.7× 111 0.9× 74 0.7× 37 0.6× 12 439
Emilios Gemenetzidis United Kingdom 11 460 1.7× 110 0.9× 251 2.1× 133 1.2× 65 1.1× 11 655
Sun Joo Lee South Korea 11 254 1.0× 69 0.6× 103 0.9× 135 1.2× 48 0.8× 14 433
Kerstin Schlüter Germany 9 191 0.7× 100 0.8× 267 2.3× 86 0.8× 109 1.8× 9 505
Wenshan Zhao China 15 219 0.8× 43 0.3× 101 0.9× 75 0.7× 109 1.8× 27 495
Abigail Hielscher United States 8 174 0.7× 87 0.7× 120 1.0× 111 1.0× 42 0.7× 12 399
Pavan Kumar Dhanyamraju United States 13 337 1.3× 48 0.4× 112 1.0× 66 0.6× 39 0.7× 24 495
Ashfaq A. Parkar United States 9 294 1.1× 262 2.1× 78 0.7× 60 0.5× 78 1.3× 12 612

Countries citing papers authored by Xiaojing Xing

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Xing more than expected).

Fields of papers citing papers by Xiaojing Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Xing. The network helps show where Xiaojing Xing may publish in the future.

Co-authorship network of co-authors of Xiaojing Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Xing. A scholar is included among the top collaborators of Xiaojing Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Xing. Xiaojing Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiya, Tingting Dai, Hongwei Wang, et al.. (2025). Novel Fe(II)-Based Supramolecular Film Prepared by Interfacial Self-Assembly of an Asymmetric Polypyridine Ligand and Its Electrochromic Performance. Molecules. 30(6). 1376–1376. 2 indexed citations
2.
Zhao, Weili, Jun Zhu, Yuqin Song, et al.. (2024). Tucidinostat plus R-CHOP in previously untreated diffuse large B-cell lymphoma with double expression of MYC and BCL2: An interim analysis from the phase III DEB study.. Journal of Clinical Oncology. 42(17_suppl). LBA7003–LBA7003. 7 indexed citations
3.
Cheng, Xinfeng, Xiya Chen, Hongwei Wang, et al.. (2024). Interfacial self-assembly of a rigid-flexible terpyridine-Fe( ii ) supramolecular film and the electrochromic performance of its solid-state devices. Journal of Materials Chemistry C. 12(45). 18327–18333. 1 indexed citations
5.
Xing, Xiaojing, et al.. (2024). Status and implications of scoping reviews in Chinese nursing research. 8(0). e2024023–e2024023. 1 indexed citations
6.
Xing, Xiaojing, et al.. (2023). Promoting effects of calponin 3 on the growth of diffuse large B‑cell lymphoma cells. Oncology Reports. 49(2). 1 indexed citations
7.
Xing, Xiaojing, et al.. (2023). FKBP3 aggravates the malignant phenotype of diffuse large B‐cell lymphoma by PARK7‐mediated activation of Wnt/β‐catenin signalling. Journal of Cellular and Molecular Medicine. 28(1). e18041–e18041. 2 indexed citations
8.
Zhao, Xuan, Xiaojing Xing, & Yongkai Wu. (2023). CircSFMBT2 Plays an Oncogenic Role in Lung Adenocarcinoma Depending on the miR-1305/SALL4 Axis. Biochemical Genetics. 62(5). 3485–3503. 1 indexed citations
10.
Xing, Xiaojing, et al.. (2022). LncRNA SNHG5 can Regulate the Proliferation and Migration of Diffuse Large B Cell Lymphoma Progression via Targeting miR-181-5p/XIAP. Journal of Cancer. 13(3). 784–792. 6 indexed citations
11.
Xing, Xiaojing, et al.. (2022). Panniculitis, an Uncommon Skin Manifestation in Adult Dermatomyositis. International Journal of Dermatology and Venereology. 6(2). 96–101.
12.
Liu, Hu, Hexin Chen, Ying Sun, et al.. (2019). The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection. SHILAP Revista de lepidopterología. 3 indexed citations
13.
Wang, Ke, Wei Zhang, Zhiyao Zhou, et al.. (2018). Implementation of good life with osteoarthritis from Denmark (GLA:DTM) in China: the pilot results and a survey on patient views and preferences. Osteoarthritis and Cartilage. 26. S317–S318. 1 indexed citations
14.
Liu, Bin, et al.. (2018). ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling. Cancer Management and Research. Volume 10. 3159–3168. 16 indexed citations
15.
Xu, Ke, et al.. (2018). A novel SWIM domain protein ZSWIM5 inhibits the malignant progression of non-small-cell lung cancer. Cancer Management and Research. Volume 10. 3245–3254. 8 indexed citations
16.
17.
Wang, Xiaogang, et al.. (2011). Successful Treatment with Bortezomib and Thalidomide for POEMS Syndrome Associated with Multicentric Mixed-type Castleman's Disease. Japanese Journal of Clinical Oncology. 41(10). 1221–1224. 17 indexed citations
18.
Zhu, Weifeng, et al.. (2000). [Study on risk factors of breast cancer among urban women in China].. PubMed. 21(3). 216–20. 9 indexed citations
19.
Xing, Xiaojing, et al.. (1997). Safety studies of the intraperitoneal injection of E1A–liposome complex in mice. Gene Therapy. 4(3). 238–243. 21 indexed citations
20.
Xing, Xiaojing, Angabin Matin, Yu Dong, et al.. (1996). Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer.. PubMed. 3(3). 168–74. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026